{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:27Z","timestamp":1759366527297,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.revmed.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:13:19Z","timestamp":1674850399000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension art\u00e9rielle\u00a0: qui traiter, jusqu\u2019o\u00f9 et comment\u00a0?"],"prefix":"10.1016","volume":"44","author":[{"given":"O.","family":"Steichen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2023.01.008_bib0245","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87\u00a0risk factors in 204\u00a0countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"GBD 2019\u00a0Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0250","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jch.13834","article-title":"Patterns of hypertension management in France in 2015: the ESTEBAN survey","volume":"22","author":"Vall\u00e9e","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.revmed.2023.01.008_bib0255","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2023.01.008_bib0260","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61\u00a0prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0265","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0000000000000972","article-title":"Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events \u2013 meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0270","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.119.044838","article-title":"Cardiovascular risk of isolated systolic or diastolic hypertension in young adults","volume":"141","author":"Lee","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2023.01.008_bib0275","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/HJH.0000000000002887","article-title":"Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension","volume":"39","author":"Thomopoulos","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0280","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/HJH.0000000000002516","article-title":"Guidelines for hypertension management in primary care: is local adaptation possible?","volume":"38","author":"Leite-Santos","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0285","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/HJH.0000000000002549","article-title":"The burden of conflicting guidelines","volume":"38","author":"Steichen","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0290","unstructured":"Prise en charge de l\u2019hypertension art\u00e9rielle de l\u2019adulte. Haute Autorit\u00e9 de sant\u00e9 n.d. https:\/\/www.has-sante.fr\/jcms\/c_2059286\/fr\/prise-en-charge-de-l-hypertension-arterielle-de-l-adulte.(accessed March 7, 2022)."},{"key":"10.1016\/j.revmed.2023.01.008_bib0295","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0300","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018\u00a0Practice Guidelines for the management of arterial hypertension of the European Society of hypertension and the European Society of cardiology: ESH\/ESC task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0305","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020\u00a0International Society of hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: a world health organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ajh\/hpy169","article-title":"Effect modification by age on the benefit or harm of antihypertensive treatment for elderly hypertensives: a systematic review and meta-analysis","volume":"32","author":"Huang","year":"2019","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0320","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0325","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0330","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration.","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0335","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/HJH.0000000000003056","article-title":"Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? A critical review","volume":"40","author":"Kreutz","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0340","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/HJH.0000000000001547","article-title":"Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials","volume":"35","author":"Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0345","doi-asserted-by":"crossref","first-page":"e026686","DOI":"10.1136\/bmjopen-2018-026686","article-title":"Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials","volume":"9","author":"Brunstr\u00f6m","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.revmed.2023.01.008_bib0350","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.01.008_bib0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels \u2013 updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0360","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.revmed.2023.01.008_bib0365","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.jacc.2017.11.004","volume":"71","author":"Reboussin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2023.01.008_bib0370","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0375","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/HYPERTENSIONAHA.118.12079","article-title":"Comparison of automated office blood pressure with office and out-off-office measurement techniques","volume":"73","author":"Pappaccogli","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0380","first-page":"CD004349","article-title":"Blood pressure targets in adults with hypertension","volume":"12","author":"Arguedas","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2023.01.008_bib0385","first-page":"CD010315","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","volume":"11","author":"Saiz","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2023.01.008_bib0390","doi-asserted-by":"crossref","first-page":"e1002389","DOI":"10.1371\/journal.pmed.1002389","article-title":"Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis","volume":"14","author":"Tucker","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0395","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ajh\/hpz182","article-title":"Self-monitoring of blood pressure in patients with hypertension-related multi-morbidity: systematic review and individual patient data meta-analysis","volume":"33","author":"Sheppard","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0400","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.118.11657","article-title":"Diagnostic thresholds for blood pressure measured at home in the context of the 2017\u00a0hypertension guideline","volume":"72","author":"Vongpatanasin","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0405","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of Blood pressure in humans: a scientific statement from the American heart association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0410","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354\u00a0randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2023.01.008_bib0415","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000\u00a0participants from 42\u00a0trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0420","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/HJH.0000000000002096","article-title":"Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Salam","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0425","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2010.08.007","article-title":"Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema","volume":"124","author":"Makani","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0430","doi-asserted-by":"crossref","first-page":"e026582","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010\u00a0to 2020: a meta-analysis involving 27\u00a0million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.revmed.2023.01.008_bib0435","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","article-title":"Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis","volume":"77","author":"Parati","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0440","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/HJH.0b013e328339f9fa","article-title":"Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice","volume":"28","author":"Corrao","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2023.01.008_bib0445","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial monotherapy and combination therapy and hypertension control the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0450","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.111.177592","article-title":"Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice","volume":"58","author":"Corrao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0455","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.112.201566","article-title":"Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study","volume":"61","author":"Gradman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.revmed.2023.01.008_bib0460","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/eurheartj\/ehy420","article-title":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension","volume":"39","author":"Rea","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2023.01.008_bib0465","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/hrt.2010.221473","article-title":"How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data","volume":"97","author":"Lasserson","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.revmed.2023.01.008_bib0470","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.7326\/M21-1456","article-title":"Adding a new medication versus maximizing dose to intensify hypertension treatment in older adults: a retrospective observational study","volume":"174","author":"Aubert","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0475","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.7326\/M21-3648","article-title":"How to intensify treatment in older patients with hypertension: is there a single answer?","volume":"174","author":"Steichen","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2023.01.008_bib0480","doi-asserted-by":"crossref","first-page":"e020599","DOI":"10.1136\/bmjopen-2017-020599","article-title":"Consensus study to define appropriate inaction and inappropriate inertia in the management of patients with hypertension in primary care","volume":"8","author":"Lebeau","year":"2018","journal-title":"BMJ Open"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:34Z","timestamp":1759337194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0248866323000073"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.01.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension art\u00e9rielle\u00a0: qui traiter, jusqu\u2019o\u00f9 et comment\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}